---
title: "Top 10 US Stock Gainers (6.10)"
description: "Insmed(INSM) rose 28.65%, with a trading turnover 1.4 Billion USD, and a year-to-date rose 31.7%. Abcellera Biologics(ABCL) rose 20.32%, with a trading turnover 51.2 Million USD, and a year-to-date ro"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/243961763.md"
published_at: "2025-06-10T22:01:01.000Z"
---

# Top 10 US Stock Gainers (6.10)

> Insmed(INSM) rose 28.65%, with a trading turnover 1.4 Billion USD, and a year-to-date rose 31.7%. Abcellera Biologics(ABCL) rose 20.32%, with a trading turnover 51.2 Million USD, and a year-to-date rose 3.1%. Metsera(MTSR) rose 15.5%, with a trading turnover 106.8 Million USD, and a year-to-date rose 95%.

NASDAQ Composite Index has rose 0.63%, with a year-to-date rose 2.1%; S&P 500 has rose 0.55%, with a year-to-date rose 2.7%; Dow Jones Industrial Average has rose 0.25%, with a year-to-date rose 0.8%.

Insmed(INSM) rose 28.65%, with a trading turnover 1.4 Billion USD, and a year-to-date rose 31.7%.

Abcellera Biologics(ABCL) rose 20.32%, with a trading turnover 51.2 Million USD, and a year-to-date rose 3.1%.

Metsera(MTSR) rose 15.5%, with a trading turnover 106.8 Million USD, and a year-to-date rose 95%.

### Related Stocks

- [INSM.US - Insmed](https://longbridge.com/en/quote/INSM.US.md)
- [ABCL.US - Abcellera Biologics](https://longbridge.com/en/quote/ABCL.US.md)
- [MTSR.US - Metsera](https://longbridge.com/en/quote/MTSR.US.md)
- [SBET.US - Sharplink](https://longbridge.com/en/quote/SBET.US.md)
- [ALT.US - Altimmune](https://longbridge.com/en/quote/ALT.US.md)
- [SEDG.US - Solaredge Tech](https://longbridge.com/en/quote/SEDG.US.md)
- [CASY.US - Casey General Stores](https://longbridge.com/en/quote/CASY.US.md)
- [TNDM.US - Tandem Diabetes](https://longbridge.com/en/quote/TNDM.US.md)
- [NVTS.US - Navitas Semiconductor](https://longbridge.com/en/quote/NVTS.US.md)
- [VG.US - Venture Global](https://longbridge.com/en/quote/VG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| SolarEdge Technologies Q4 Earnings Report: What Investors Need to Know | SolarEdge Technologies (NASDAQ:SEDG) reported Q4 earnings on February 18, 2026, beating estimates by 64.1% with an EPS o | [Link](https://longbridge.com/en/news/276229789.md) |
| Breaking Down Insmed: 16 Analysts Share Their Views | In the latest quarter, 16 analysts provided mixed ratings for Insmed (NASDAQ:INSM), with an average 12-month price targe | [Link](https://longbridge.com/en/news/276472105.md) |
| Tandem Diabetes Shares Rise 33% On Earnings Beat, Margin Expansion, Growth Outlook | Tandem Diabetes Care (NASDAQ:TNDM) shares surged 33% following a better-than-expected earnings report, with a smaller ad | [Link](https://longbridge.com/en/news/276472238.md) |
| Assessing Tandem Diabetes Care: Insights From 10 Financial Analysts | 10 financial analysts have evaluated Tandem Diabetes Care (NASDAQ:TNDM), showing mixed sentiments with an average 12-mon | [Link](https://longbridge.com/en/news/276444490.md) |
| Tandem Diabetes Care Swings to Q4 Loss, Sales Up; Issues 2026 Sales Outlook | Tandem Diabetes Care reported a Q4 net loss of $0.01 per diluted share, compared to earnings of $0.01 a year earlier, wh | [Link](https://longbridge.com/en/news/276425482.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
